Levodopa, or L-dopa, is considered the most effective treatment for Parkinson's disease today. After a few years of treatment, however, almost all patients develop a debilitating side-effect called ...
A discovery with major implications for cancer treatment has been made by a team of researchers from Rensselaer Polytechnic Institute (RPI), the University of Nebraska Medical Center (UNMC), ...
Quality of life in survivors of chemoradiation of the cervix. Background: To assess the interactions and dynamics of the hedgehog (Hh) and Wnt pathway activation levels in three ovarian carcinoma cell ...
The panel examine toxicity and morbidity considerations for the use of hedgehog pathway inhibitors in BCC. This is a video synopsis/summary of a Peer Exchange involving Jason Luke, MD, FACP; ...
Effect of plasma SPARC on outcome in cancer models. Background: The hedgehog (Hh) pathway plays a crucial role in the growth and patterning during embryonic development. We have shown that Hh pathway ...
Promising results from a phase 2 trial of ENV-101, a novel hedgehog inhibitor, showed improvement in lung function and reduction of fibrosis in patients with idiopathic pulmonary fibrosis, said Paul ...
Please provide your email address to receive an email when new articles are posted on . Adverse events reported with ENV-101 have been seen with other hedgehog inhibitors. Another trial is already ...
Levodopa, or L-dopa, is considered the most effective treatment for Parkinson's disease today. After a few years of treatment, however, almost all patients develop a debilitating side-effect called ...
NEW YORK, September 22, 2021 – Levodopa, or L-dopa, is considered the most effective treatment for Parkinson’s disease today. After a few years of treatment, however, almost all patients develop a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results